Schistosomiasis as a risk factor for bladder cáncer. Central Hospital of Nampula, Mozambique
Keywords:
bladder cancer, schistosomiasis, cystitis, hematuriaAbstract
Introduction: schistosomiasis is the most important trematode infection globally. Squamous cell carcinoma constitutes 2% of all the histological types of bladder cancer; however, the incidence of this variety of cancer in squistosomiasis-endemic countries is higher.
Objective: to evaluate the relationship between squistosomiasis and bladder cancer in patients from the Central Hospital of Nampula.
Materials and methods: a cross-sectional descriptive observational study was carried in the period between January 2014 and December 2020. Patients were divided into age-groups, by 10-year intervals. Biopsy samples of bladder tumors were taken, classified by histological type, in addition to findings related to squistosomiasis infestations and bladder cancer presentation forms. The universe consisted of 184 patients and the sample of 135 cases.
Results: it was found that the largest number of patients with bladder cancer is male; squamous cell carcinoma is the most frequent histological type, representing 84.3% of the total. Cystitis, schistosome and their eggs were present in almost all the biopsies performed. Its most frequent presentation forms were hematuric and painful cystitis.
Conclusions: bladder cancer showed higher incidence at the ages between 30 and 69 years. The squamous cell carcinoma was the most frequent, and its relationship with cystitis and schistosome infection was present in more than 90% of biopsies.
Downloads
References
2. Organización Mundial de la Salud. Esquistosomiasis [Internet]. Ginebra: OMS; 2021 [actualizado 18/05/2021; citado 25/09/2021]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/schistosomiasis
3. Sigarroa NB, Salazar NB, Namugenyi A, et al. Complicaciones de la esquistosomiasis urinaria crónica. Rev Cubana Urol [Internet]. 2020 [citado 15/10/2021];9(1):[aprox. 10 pantallas]. Disponible en: http://revurologia.sld.cu/index.php/rcu/article/view/557
4. Donate Moreno MJ, Pastor Navarro H, Giménez Bachs JM, et al. Vesical schistosomiasis, case report and Spanish literature review. Actas Urol Esp. 2006 Jul-Ago;30(7):714-9. Citado en PubMed; PMID: 17058618.
5. World Health Organization. Atlas of the Global Distribution of Schistosomiasis. Mozambique and Malawi. Geneva: WHO; 1987. p. 223-31.
6. Gama Vaz R. Schistosomiase e carcinoma da bexiga. Revista médica de Moçambique [Internet]. 1993 [citado 15/10/2021];4(2):2-5. Disponible en: https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4816601
7. Grau-Pujol B, Massangaie M, Cano J, et al. Frequency and distribution of neglected tropical diseases in Mozambique: a systematic review. Infec Dis Poverty [Internet]. 2019 [citado 25/09/2021];8(1):1-11. Disponible en: https://idpjournal.biomedcentral.com/articles/10.1186/s40249-019-0613-x
8. Patel SM, Rizza SA. The porcelain bladder: Schistosomiasis. Am J Med [Internet]. 2012 [citado 13/10/2021];125(12):1178-80. Disponible en: https://www.amjmed.com/article/S0002-9343(12)00683-3/fulltext
9. Cumberbatch MGK, Jubber I, Black PC, et al. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018. Eur Urol [Internet]. 2018 [citado 15/10/2021];74(6):784-95. Disponible en: https://www.clinicalkey.es/#!/content/journal/1-s2.0-S0302283818306511
11. O'Hara J. Mayo Clinic Q&A podcast: Bladder cancer patients require ongoing surveillance. Minnesota: Mayo Clinic [Internet]. 2021 may 17 [citado 15/10/2021]. Disponible en: https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-qa-podcast-bladder-cancer-patients-require-ongoing-surveillance/
12. Parkin DM. The global burden of urinary bladder cancer. Scand J Urol Nephrol [Internet]. 2008 [citado 15/10/2021];42(Supl 218):12-20. Disponible en: https://www.tandfonline.com/doi/abs/10.1080/03008880802285032
13. Antoni S, Ferlay J, Soerjomataram I, et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol [Internet]. 2017 [citado 15/10/2021];71(1):96-108. Disponible en: https://www.clinicalkey.es/#!/content/journal/1-s2.0-S0302283816302809
14. Sociedad Americana contra el Cáncer. Tasas de supervivencia del cáncer de vejiga. American Cancer Society [Internet]. 2021 Feb [citado 16/10/2021]. Disponible en: https://www.cancer.org/es/cancer/cancer-de-vejiga/deteccion-diagnostico-clasificacion-por-etapas/tasas-de-supervivencia.html
15. González Resina R, Sánchez Bernal ML, Pérez Espejo MP, et al. Carcinoma epidermoide vesical: Revisión de nuestra serie. Arch Esp Urol [Internet]. Oct 2006 [citado 16/10/2021];59(8):785-90. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0004-06142006000800005&lng=es
16. International Agency for Research on Cancer. Global Cancer Observatory. World Health Organization [Internet]. Mar 2021 [citado 16/10/2021]. Disponible en: https://gco.iarc.fr/today/data/factsheets/populations/508-mozambique-fact-sheets.pdf
17. Adeloye D, Harhay MO, Ayepola OO, et al. Estimate of the incidence of bladder cancer in Africa: A systematic review and Bayesian meta-analysis. Int J Urol [Internet]. 2019 [citado 16/10/2021];26(1):102-12. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.13824
Downloads
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.
Guidelines to authors
